Product Information
Dilpacimab (ABT165) is a dual-target antibody for DLL4 and VEGF, used in cancer research.
Chemical properties
Technical inquiry about: TM-T77157 Dilpacimab
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.